AI
JNJ icon

Accredited Investors’s Johnson & Johnson JNJ Stock Holding History

Accredited Investors’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.02M Buy
7,952
+789
+11% +$184K 0.09% 75
2026
Q1 		$1.75M Sell
7,163
-1,487
-17% -$346K 0.09% 76
2025
Q4 		$1.79M Buy
8,650
+844
+11% +$167K 0.1% 75
2025
Q3 		$1.45M Sell
7,806
-684
-8% -$117K 0.08% 81
2025
Q2 		$1.3M Sell
8,490
-24
-0.3% -$3.69K 0.08% 83
2025
Q1 		$1.41M Buy
8,514
+315
+4% +$49.3K 0.09% 76
2024
Q4 		$1.19M Buy
8,199
+298
+4% +$46.2K 0.07% 84
2024
Q3 		$1.28M Buy
7,901
+301
+4% +$48K 0.07% 83
2024
Q2 		$1.11M Buy
7,600
+369
+5% +$54.9K 0.07% 85
2024
Q1 		$1.14M Buy
7,231
+16
+0.2% +$2.55K 0.07% 85
2023
Q4 		$1.13M Sell
7,215
-82
-1% -$12.6K 0.08% 82
2023
Q3 		$1.14M Sell
7,297
-337
-4% -$55.6K 0.09% 77
2023
Q2 		$1.26M Sell
7,634
-20
-0.3% -$3.23K 0.09% 73
2023
Q1 		$1.19M Sell
7,654
-412
-5% -$66.5K 0.09% 70
2022
Q4 		$1.42M Buy
8,066
+1,143
+17% +$197K 0.12% 58
2022
Q3 		$1.13M Sell
6,923
-47
-0.7% -$7.95K 0.13% 59
2022
Q2 		$1.24M Sell
6,970
-50
-0.7% -$8.91K 0.15% 57
2022
Q1 		$1.24M Buy
7,020
+40
+0.6% +$6.81K 0.11% 67
2021
Q4 		$1.19M Buy
6,980
+441
+7% +$72.2K 0.11% 67
2021
Q3 		$1.06M Buy
6,539
+358
+6% +$61.1K 0.11% 63
2021
Q2 		$1.02M Buy
6,181
+124
+2% +$20.5K 0.1% 69
2021
Q1 		$996K Sell
6,057
-367
-6% -$59.4K 0.13% 69
2020
Q4 		$1.01M Buy
6,424
+1,249
+24% +$184K 0.17% 61
2020
Q3 		$770K Buy
5,175
+95
+2% +$14.1K 0.16% 66
2020
Q2 		$714K Buy
5,080
+13
+0.3% +$1.89K 0.15% 68
2020
Q1 		$664K Sell
5,067
-531
-9% -$75.3K 0.16% 63
2019
Q4 		$817K Buy
5,598
+558
+11% +$75.7K 0.14% 64
2019
Q3 		$652K Sell
5,040
-475
-9% -$62.6K 0.13% 70
2019
Q2 		$768K Sell
5,515
-172
-3% -$23.8K 0.15% 64
2019
Q1 		$795K Buy
5,687
+515
+10% +$69K 0.16% 61
2018
Q4 		$667K Sell
5,172
-73
-1% -$10.2K 0.15% 59
2018
Q3 		$725K Sell
5,245
-1,456
-22% -$193K 0.18% 51
2018
Q2 		$813K Buy
6,701
+1,491
+29% +$186K 0.21% 42
2018
Q1 		$668K Buy
5,210
+219
+4% +$29.6K 0.18% 45
2017
Q4 		$697K Buy
4,991
+59
+1% +$8.22K 0.19% 46
2017
Q3 		$641K Buy
4,932
+139
+3% +$18.4K 0.18% 54
2017
Q2 		$634K Buy
4,793
+440
+10% +$56.1K 0.16% 43
2017
Q1 		$542K Buy
4,353
+119
+3% +$14.2K 0.14% 53
2016
Q4 		$488K Sell
4,234
-6
-0.1% -$693 0.13% 57
2016
Q3 		$501K Sell
4,240
-784
-16% -$95.1K 0.14% 54
2016
Q2 		$535K Buy
5,024
+1,099
+28% +$125K 0.15% 54
2016
Q1 		$425K Buy
3,925
+416
+12% +$43.1K 0.11% 63
2015
Q4 		$361K Buy
3,509
+116
+3% +$11.7K 0.09% 66
2015
Q3 		$317K Buy
3,393
+323
+11% +$31.2K 0.09% 63
2015
Q2 		$293K Sell
3,070
-56
-2% -$5.61K 0.08% 58
2015
Q1 		$315K Sell
3,126
-92
-3% -$9.36K 0.08% 56
2014
Q4 		$337K Sell
3,218
-244
-7% -$25.7K 0.1% 50
2014
Q3 		$367K Sell
3,462
-97
-3% -$10.1K 0.11% 48
2014
Q2 		$373K Sell
3,559
-151
-4% -$15.3K 0.12% 43
2014
Q1 		$365K Buy
3,710
+17
+0.5% +$1.58K 0.12% 42
2013
Q4 		$339K Sell
3,693
-19
-0.5% -$1.75K 0.12% 40
2013
Q3 		$322K Sell
3,712
-94
-2% -$8.43K 0.12% 41
2013
Q2 		$327K Buy
+3,806
New +$323K 0.13% 40

Other funds holding JNJ

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Accredited Investors's JNJ Position: Q2 2026 in Review

Accredited Investors increased its Johnson & Johnson (JNJ) stake by 11% in Q2 2026, buying an estimated $184K and bringing the position to 7,952 shares worth $2.02M. The position accounts for 0.09% of the portfolio, ranked #75.

Accredited Investors first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Accredited Investors held 7,952 shares of Johnson & Johnson worth $2.02M as of Q2 2026.
  • Accredited Investors bought 789 Johnson & Johnson shares in Q2 2026, an estimated $184K.
  • Johnson & Johnson made up 0.09% of Accredited Investors's portfolio in Q2 2026, its #75 holding.
  • Accredited Investors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Accredited Investors's 13F filing for Q2 2026, filed 21 Jul 2026.